ClinicalTrials.Veeva

Menu

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

F

Federico II University

Status

Completed

Conditions

Macular Degeneration Choroidal Neovascularization

Treatments

Diagnostic Test: Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter

Study type

Observational

Funder types

Other

Identifiers

NCT05969418
05809850

Details and patient eligibility

About

To evaluate the activity of neovascular macula degeneretion as assessed by SD-OCTand OCT-A using a split-person study design and deep-learning quantification.

Full description

Exudative neovascular macular degeneration is the primarily an age-related retinal condition The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features in order to choose the best therapy .

The study evaluates the changes in structural optical coherence tomography and optical coherence tomography angiography features in neovascular macular degeration patients undergoing ANTI-VEGF treatments using artificial intelligence.

Enrollment

50 patients

Sex

All

Ages

50 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: age older than 50 years

  • diagnosis of neovascular macular degeneration
  • absence of previous retinal surgery and congenital eye diseases.
  • absence of errors of refraction
  • absence of lens opacities
  • absence of low-quality OCT and OCTA images

Exclusion Criteria:• age younger than 50 years

  • previous retinal surgery and congenital eye diseases
  • errors of refraction
  • lens opacities
  • low-quality OCT and OCTA images

Trial design

50 participants in 2 patient groups

Patients with neovascular macular degeneration
Treatment:
Diagnostic Test: Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter
healty patients matched age and sex without any ocular disease
Treatment:
Diagnostic Test: Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter

Trial contacts and locations

1

Loading...

Central trial contact

Gilda Cennamo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems